Amedisys (AMED) PT Raised to $133 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amedisys (AMED) PT Raised to $136 at UBS
March 1, 2019 6:58 AM ESTUBS raised its price target on Amedisys (NASDAQ: AMED) to $136.00 (from $126.00) while maintaining a Neutral rating.
... MoreAmedisys (AMED) PT Raised to $140 at Oppenheimer
February 28, 2019 4:17 PM ESTOppenheimer analyst Michael Wiederhorn raised the price target on Amedisys (NASDAQ: AMED) to $140.00 (from $137.00) while maintaining a Outperform rating.
... MoreAmedisys (AMED) PT Lowered to $124 at Craig-Hallum
February 28, 2019 3:52 PM ESTCraig-Hallum analyst Kevin Ellich lowered the price target on Amedisys (NASDAQ: AMED) to $124.00 (from $132.00) while maintaining a Hold rating.
Ellich notes FY19 guidance was lower partially due to CCH integration.
... More